EG BIOMED CO., LTD.
Area: Country Pavilion
Booth No: M710
Website: https://eg-bio.com/
Exhibitor Profile
EG BioMed develops non-invasive, DNA methylation-based blood tests for early multi-cancer detection. With proprietary probes and automated qPCR, we provide a sensitive, trackable platform. Our pancreatic cancer test is available, with assays for breast, colorectal, and lung cancers in development.
We operate a CLIA-certified lab in Washington (CLIA ID: 50D2316600) and are pursuing CAP accreditation. Our Taiwan facility is certified under ISO 13485, ISO 15189, and LDTs.
Brands
EG BIOMED CO., LTD.
Video
Exhibit Products
-
EG-Colon Blood Test-E1 Early-Stage Colorectal Cancer Blood Test
-
EG-Breast Blood Test-P1 Breast Cancer Follow-Up Blood Test
-
EG-Pancreatic Blood Test-E1 Pancreatic Cancer Blood Testing
Exhibitor Press Release
- EG BioMed Supports Pancreatic Cancer Awareness at PurpleStride 2025 2025-05-20
- EG BioMed’s Certified DNA Test for Early Cancer Detection 2025-05-20
Exhibitors you may be interested in
Highest Rated